{"directed": true, "multigraph": true, "graph": {"pybel_version": "0.13.1-dev", "document_metadata": {"name": "Free radical formation subgraph", "version": "5.1.2", "copyright": "Copyright © 2019 Fraunhofer SCAI, All rights reserved.", "licenses": "CC BY 4.0", "contact": "daniel.domingo.fernandez@scai.fraunhofer.de"}, "namespace_url": {"CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/chebi-names.belns", "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns", "GFAM": "https://raw.githubusercontent.com/pharmacome/terminology/3f89d31906739fce9678d868b6a599a851aa7c00/external/hgnc.genefamily-names.belns", "GO": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/go.belns", "HBP": "https://raw.githubusercontent.com/pharmacome/terminology/570376e4c233483b667eab12a1f964950368282a/export/hbp-names.belns", "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/hgnc-symbols.belns", "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/mesh.belns", "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns", "CTO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/clinical-trial-ontology/clinical-trial-ontology-1.0.0.belns", "DO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20170725.belns", "GOBP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go-biological-process/go-biological-process-20170725.belns", "GOCC": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go-cellular-component/go-cellular-component-20170725.belns", "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns", "MESHC": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-chemicals/mesh-chemicals-20170725.belns", "MESHCS": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-cell-structures/mesh-cell-structures-20170511.belns", "MESHD": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-diseases/mesh-diseases-20170725.belns", "MESHPP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-processes/mesh-processes-20170725.belns", "MGI": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mgi-mouse-genes/mgi-mouse-genes-20170725.belns", "RGD": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/rgd-rat-genes/rgd-rat-genes-20170725.belns", "SCOMP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-named-complexes/selventa-named-complexes-20170725.belns", "SFAM": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-protein-families/selventa-protein-families-20170725.belns", "INTERPRO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/interpro/interpro-20170731.belns", "ADO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/alzheimer-disease-ontology/alzheimer-disease-ontology-1.0.2.belns", "BRCO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/brain-region-ontology/brain-region-ontology-1.0.0.belns", "NIFT": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/imaging-ontology/imaging-ontology-1.0.6.belns", "PTS": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/neurodegeneration-pathways/neurodegeneration-pathways-1.0.0.belns"}, "namespace_pattern": {"DBSNP": "^rs\\d+$", "TAXONOMY": "^\\d+$"}, "namespaces_uncached": [], "annotation_url": {"Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno", "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno", "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno", "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno", "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno", "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno", "Gender": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno", "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno", "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno", "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno", "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"}, "annotation_pattern": {"Species": "\\d+"}, "annotation_list": {"Duration_of_Chemical_Exposure": ["Chronic", "Subchronic"], "NIFT": ["Positron Emission Tomography", "Volumetric MRI"], "Published": ["CDR story", "Epilepsy comorbidity paper"], "Race": ["Caucasian", "Chinese", "Colombian", "Italian", "Swedish", "Taiwanese"], "Condition": ["Normal Healthy State"], "Encode_Feature_Types": ["Promoter"], "Experimental_Group": ["Physical exercised group", "Sedentary group"], "KnockoutMice": ["App transgenic"], "DiseaseState": ["Early-onset AD", "Familial Alzheimers Disease", "Late-onset AD", "Mild AD", "Moderate AD", "Sporadic Alzheimers Disease"], "FDASTATUS": ["Phase 2", "Phase 3"], "UserdefinedCellLine": ["293APPwt", "App transgenic", "CHOAPPsw", "INS-1 cells", "N2a695 cell", "NT2N cells", "Neuroblastoma cell", "primary cortical neuron", "primary neuron"], "Patient": ["AD T2DM +ve", "AD T2DM -ve", "APOE e4 +ve", "APOE e4 -ve"], "Developmental_Phase__of_patient": ["Developmental stage", "Old"], "Transcriptionally_active_region": ["3 prime UTR", "5 prime UTR"]}}, "nodes": [{"function": "Abundance", "namespace": "CHEBI", "name": "amyloid-beta", "id": "a9487b29439483c6840095610dd3e496e3ca9cccc3a8d71e0385a39b570f3c0a26965ac06d83265e1c08deaae7998272d4f4c21ec0534f8be3fd8e4e57dbb3a2"}, {"function": "Abundance", "namespace": "CHEBI", "name": "copper(1+)", "id": "03be4d8a657a0809f2297870f38a35f128fa3b54af7e25903d2283d7b79573a497388d1d539b34db40babd399476acdd4bda0e583b6199b0cd31146077febe7b"}, {"function": "Abundance", "namespace": "CHEBI", "name": "copper(2+)", "id": "14ead2ae871c8e415828e6ad4287fa4ff903d12c9fa5c12eeb36ac2b73b287beccc5511e4ffc19c059cc45ab16188f560d4d71fa03eefda3cd971f7c87adfbf3"}, {"function": "Abundance", "namespace": "CHEBI", "name": "hydrogen peroxide", "id": "4d65b5d180890b98afe0bc10614fde44ee750b2d1af6fdd925fc31ead7ee9a7248bda3d67c52aebf220b8c048d999f2d878a97a70b0e027a7294cbd3c7bf61bf"}, {"function": "Abundance", "namespace": "CHEBI", "name": "hydroxy group", "id": "8e25ca07e53d939419d6644766c4e46072bc22eab8bd0bc22a0bb946e21a1289684ff5159fff024269d0453da258dc5182d88dedfce5630a0bec2fd3b2865009"}, {"function": "Abundance", "namespace": "CHEBI", "name": "iron(3+)", "id": "fce8e3b8ec9550d6bbb414323fafe4d0e652c11ce4baf1567f6f6550ffe5f9f6d75dbb78be9050828d0696a463d66f41e7ffec7c9d8b3ffd248b34bffbc87633"}, {"function": "Abundance", "namespace": "CHEBI", "name": "ATP", "id": "dbc5553fb6213ed82215c03a89950a37045e23683ffa96b44532f3e75d204cc547a974025c2799c6a189ad0c5045d96b16d1f5f7ac9296473ba1c647499bb3b2"}, {"function": "Abundance", "namespace": "CHEBI", "name": "Isorhynchophylline", "id": "7c4671fea666b35164e254a45c79431cc8b619b959c291d246dd4dffb9b2c413d0d4c4364a3543b90147e0ea6611907764c5df32cb6723a98e82bb274dfe9571"}, {"function": "Abundance", "namespace": "CHEBI", "name": "berberine", "id": "e57e7808372e142d1dba445b83ec643c6330f0d1bd2804c0331e332e1e26433cc8b8c9f47fa38a72ca59b1ad3651943329349f590ed90906a4c558eb9c0109ff"}, {"function": "Abundance", "namespace": "CHEBI", "name": "glutathione", "id": "a75431c9ce7065ec867a86011c2371dd04187869fb2f21220cb8b8686a5a63863e8f98d2e96f23b6133fe39f75169f6798972c8cae9fa7bcb3af79562e948af1"}, {"function": "Abundance", "namespace": "CHEBI", "name": "isoprostane", "id": "1c7989fe7cbf84d906325975fea5a21a83ebfc1fcca29bff372a98a5874be58e45c8475d7beface96200964413b7e681d9e7011aad8b05f107ec6aa1dc8c65b0"}, {"function": "Abundance", "namespace": "CHEBI", "name": "melatonin", "id": "4a1325d59f8945be15d4cc8d58d99dde51fa1eee92f26963ab3c8319ffbf0101fed910b9103656b277b31da093724ce847b1fc3004d39022f3656116ceb8a53e"}, {"function": "Abundance", "namespace": "CHEBI", "name": "radical", "id": "d617625aefa0dd6bb5eb8de723190b733e33f65cf2f5f44a9ca3650465e6003f044763248f2e29acaa69696513006efe265695c6c15b62569d35a2462a61e998"}, {"function": "Abundance", "namespace": "CHEBI", "name": "rivastigmine", "id": "317d5b18448e148088204c7a7dce78316c0ea8b56c70a7adaffe344826b17688e05873b2746050d29c18ae658658e81a2d775ba56b6f5abf8821f4eaca725064"}, {"function": "Abundance", "namespace": "CHEBI", "name": "rutin", "id": "739498999bc9225cdf70bed7baccc6155b8902feead9b3acd9ee82d95bcfb1418a5e1f04f9512089559c9d06a4b19fef20ccfd8c4c92d33226add74450d003b3"}, {"function": "Abundance", "namespace": "CHEBI", "name": "superoxide", "id": "ed3ac1e9301fd508195472cf5c9e0ffe33baed921bb114f59f003bda692d466b1b57b05211ca84118e55ea8dfd5855f1ff5c8cc781ae4a76bb62202fe55a9124"}, {"function": "Abundance", "namespace": "MESHC", "name": "Free Radicals", "id": "e0b0d5e69bc5572a80e788f2c45e29345e146e45f0bc851f9f829f51c2641ced62f57ad6c46048763f0d022ab2832bcf697f862f50e48bf83bcc46a11a111617"}, {"function": "BiologicalProcess", "namespace": "GOBP", "name": "electron transport chain", "id": "6d79a5a2bb9b6ec4267f5d4f23650029be752f2e3a95e5e3eeb5da3fd0f69674e31b8cb3ff0ac5cdf3e4e7b0709f4df76173a7b72a034cab87a7e214259deb7b"}, {"function": "BiologicalProcess", "namespace": "GOBP", "name": "mitochondrial calcium ion homeostasis", "id": "94586e25d4cb788b3304300007315c4def867fceea8b4499b18216c5ce45fdf05f7e84a973552a06bdf12e03d219b4f99b6959748ed19f515fc2d316f8c0453a"}, {"function": "BiologicalProcess", "namespace": "GOBP", "name": "neuron death", "id": "7a2f309b1d4a7c1ab86704418e6cffe1e917c5d1d842312e825776263f2ae593e2d871381b4a4bacf2efab95f6f8e1d9264f5e025c7676621a1e72a9e74d7c85"}, {"function": "BiologicalProcess", "namespace": "GOBP", "name": "regulation of glutathione peroxidase activity", "id": "b905b19091c926dffe99c002cdce9a76e546db1f344eb7ae6803f6d158c385e2ec7ac203a1dbaf18044d3ab5a746b8b16c28ff5e439d3dd3cf8fa04a6f9ea1db"}, {"function": "BiologicalProcess", "namespace": "GOBP", "name": "regulation of histone deacetylase activity", "id": "40f9e9c636d78459a3f7cf3107b54cc73074954c69f06c52bbfa4aa5c4b88f159c852840a68e3623b3268cd623406e632873518ac329bf714e5efb58c417c5a0"}, {"function": "BiologicalProcess", "namespace": "GOBP", "name": "regulation of superoxide dismutase activity", "id": "e3986701767713ecf6e8228d6c92ece569e519736171119fef985d43b7d069ae0d56d3e52aae3b91a8a36f57ced8f8a0d6fbc580776016528ef88373b2174dd1"}, {"function": "BiologicalProcess", "namespace": "GOBP", "name": "response to oxidative stress", "id": "a102c12e30559a8d58a9ad0a290b9f0830898de52dc176810348cc207194be3490f8e38df97987bea8b5827f54a61ed09445e86a065fe9b27a51db2f861de59c"}, {"function": "BiologicalProcess", "namespace": "GOBP", "name": "learning", "id": "ee36290ab8226f450927c8f0073441e739a71eb8b905ce1e756df6ee75a571e76233bf7eeb01a829aa10342883ae0eef8728a3920800c85035fa43b364c2de13"}, {"function": "BiologicalProcess", "namespace": "MESHPP", "name": "Oxidative Stress", "id": "2e38d6f16f5bdfbc33da58532c5bdd2a6e47cde3f52748b83013a33fc1a076ae93e2852e3d3559e7e4b130cae695a61f746fe7fd8b5929ac3761040a5474b31a"}, {"function": "Complex", "members": [{"function": "Abundance", "namespace": "CHEBI", "name": "copper(1+)", "id": "03be4d8a657a0809f2297870f38a35f128fa3b54af7e25903d2283d7b79573a497388d1d539b34db40babd399476acdd4bda0e583b6199b0cd31146077febe7b"}, {"function": "Abundance", "namespace": "CHEBI", "name": "hydrogen peroxide", "id": "4d65b5d180890b98afe0bc10614fde44ee750b2d1af6fdd925fc31ead7ee9a7248bda3d67c52aebf220b8c048d999f2d878a97a70b0e027a7294cbd3c7bf61bf"}], "id": "6120750d2fb40fa341317c7dd0d557bec48ae61e2614b7aba14a68508f0796e2db28d607bc0b1efb93eeadb5d80d0dd98a0d4ee92cbf1f58a7dc4d155ef8c2a9"}, {"function": "Complex", "members": [{"function": "Abundance", "namespace": "CHEBI", "name": "hydrogen peroxide", "id": "4d65b5d180890b98afe0bc10614fde44ee750b2d1af6fdd925fc31ead7ee9a7248bda3d67c52aebf220b8c048d999f2d878a97a70b0e027a7294cbd3c7bf61bf"}, {"function": "Abundance", "namespace": "CHEBI", "name": "iron(2+)", "id": "e426e7ad4ee4d8eb3c018acb75625d794a96811eb659d39bd8f25c4b30632fc8a938eca8397887738ecc384ec5df867e2026de113f002e5cc4490177de0905cd"}], "id": "2d9e840fc1bcfb52c95f3305785f99774083a8bd9697574aae7dfcc82d443741c819a28fde55d9954ea88dca75dc6cf1b85b3e415f9ff79c620e1e5e298b15d7"}, {"function": "Complex", "members": [{"function": "Protein", "namespace": "HGNC", "name": "APP", "variants": [{"kind": "frag", "start": 672, "stop": 713}], "id": "3e5de8e845a1a7b00bc3bcb2e2ce192ad8c91a9c1beb7f894571f750d8d4cbcfb96c2dcabb2c5f461e38a63cd31bbb7233e393cfba29dea19455033cd38fbe28"}, {"function": "Protein", "namespace": "HGNC", "name": "HSD17B10", "id": "c85464d1c7b25076a4e639b0ec364edc47f5d6c54b8fafbb5b8e83a9592a87cd721af6e11cd40ed09d6f3d6a01f1057b485a8d4cab358267be015b2e49e52228"}], "id": "49480ef2a15c845c34e8e4db1c9f5cca673b592924b59cf301cb575d3a167fdb6546db8349865eb855607acb635c8b42b14333476492bc0b165b5f09ed9cb6de"}, {"function": "Protein", "namespace": "ECCODE", "name": "1.15.1.1", "id": "3ef424345b6f2308585794d699e74cb7290c6e19e30da1ae27186edc922a7ff268be5528b1cdba14f18b82ceb7d10a91fe1477ff657c572e5db0bc221ae02c9c"}, {"function": "Protein", "namespace": "FPLX", "name": "SOD", "id": "a15a55de3bf124627aabcd66e182df4019bd37a501572902da3ccb8f2625a59a2939f14039ca5c4e05991415eed2d8f72c19f9c5782d10e56d6f5011f8631646"}, {"function": "Protein", "namespace": "HGNC", "name": "APP", "id": "ed1d45f3255226e4210017e6c179950e0e04a300727326d7fea6a9659868e8818ff64fd5e8a2a92a703fb1566b3f48323750ac6c28e7adb40843053d276710bc"}, {"function": "Protein", "namespace": "HGNC", "name": "APP", "variants": [{"kind": "frag", "start": 672, "stop": 713}], "id": "3e5de8e845a1a7b00bc3bcb2e2ce192ad8c91a9c1beb7f894571f750d8d4cbcfb96c2dcabb2c5f461e38a63cd31bbb7233e393cfba29dea19455033cd38fbe28"}, {"function": "Protein", "namespace": "HGNC", "name": "CAT", "id": "e7153f9f1498777b5ab16f683398f985c7464db8ca0c13c496ba5ebbb4c11e3c571408d985cae8e6ac5fe7d4639b82020aba1035c939850a8fd5719e75a5075b"}, {"function": "Protein", "namespace": "HGNC", "name": "HSD17B10", "id": "c85464d1c7b25076a4e639b0ec364edc47f5d6c54b8fafbb5b8e83a9592a87cd721af6e11cd40ed09d6f3d6a01f1057b485a8d4cab358267be015b2e49e52228"}, {"function": "Protein", "namespace": "HGNC", "name": "KEAP1", "id": "ac5b90f683c70d7c98852200b82d97e1b9c6dadc08a979341fb205cb99aa201796fb24c5c1c2e69b24015d83c9aa6da9f6e2f257aadde2ba87accdb9f5366e7b"}, {"function": "Protein", "namespace": "HGNC", "name": "MAPK14", "id": "7c10ba4aa52bc8cb24fca9be53229a6eafa3cf7979169443f5748eac1db12270556317043e9ffdd7e8ad9225bf8825aa187b298f8566ac3c3e8ae485a0ce8656"}, {"function": "Protein", "namespace": "HGNC", "name": "NFE2L2", "id": "f707e81d79f55da8c33a4f0fad8eda52a2960c3256f2cd831a5d51542d824e4ed26a18f97cebba93ca1b75239d492efaa0acefa07f5cb15dd98f75c9078ac249"}, {"function": "Protein", "namespace": "HGNC", "name": "SOD1", "id": "7bebe84ddc870a4ceb70828bba41ec797b861126138342942eb8124edaef94657501d4b9c4a69876b38e0fba2ff4cd5a91b560173b73723f03809ed503e90e98"}, {"function": "Protein", "namespace": "MGI", "name": "Nfe2l2", "id": "ca5db172043ef01a28448899ca79737eaba71966fd12f33a2ac47b7a96a80b0818798fa4693d9517f0e4cc1ec2847ebd3fedeb6a92fd6a7a8fc9e5b2d9767439"}, {"function": "Protein", "namespace": "MGI", "name": "Sod1", "id": "0a0c9eb82637c52ee1684eb1c168066ccb246f388999f4a9d70ce6b8c4d3296eec80fda9b3bd9bcbd820baf3d49cef02f48843b7d1c5d9000600d3a984aa2df3"}, {"function": "Protein", "namespace": "RGD", "name": "Sod1", "id": "a759edba8d31b05caa15f6431013be9cadcf55df8f987156d304a70c1ed5e3a0219dd104220c96c26bd2ea534597d667dd5e90b0cbbd30b771f15e95785b1e9d"}, {"function": "Protein", "namespace": "RGD", "name": "Sod2", "id": "d835e72fd06b0479903b96776749eef28186a3dd2930a5d5f9f7b553c8e8e49373256417f7d250d0ad0f69a9aae50246fb367fca1dd044f1fe329513cbf487ce"}, {"function": "Pathology", "namespace": "MESHD", "name": "Alzheimer Disease", "id": "0893d59040331bc1b155187396067458820ab2635e0138b840323082d33d44b964ab1240f5aeb64c5360e1340de40545835bc744c181abb910d64c923d55ff2b"}, {"function": "Pathology", "namespace": "MESHD", "name": "Amyotrophic Lateral Sclerosis", "id": "3e1fa5076e54f5083905d6930cb719a5e61219f9e1a03a57f6077e8d75596326a696753cf8fa852e9de1c0530de7df6ded7690d695bbed7a4d268e8b7dbed513"}, {"function": "Pathology", "namespace": "MESHD", "name": "Brain Edema", "id": "f777c66be161f2735d5766ce01164ebf90e5561f1337030625108f7a9261678549d2d43795d1d029612bd76a791b4855eca08cb4a9c2693af5c2ac12744889ae"}, {"function": "Pathology", "namespace": "MESHD", "name": "Parkinson Disease", "id": "bb8b58327c126d5101cfa34fcf393f5d91d9a57382d6cd537a66f17946f11c09c1dddc2a6d838f174e68f07cf9f1e7473d3c9f44189af6888ee35b7ac78838a8"}, {"function": "Pathology", "namespace": "MESHD", "name": "Wounds and Injuries", "id": "e65bc70597fa3a02d4117879b2e16b0820a01d2ca712af995ed1ac7ad447b9ff79f661a77249a4f96e6faf9e01f64955c1c343fd5254cea2aaae5d12ab560190"}, {"function": "Pathology", "namespace": "MESHD", "name": "Inflammation", "id": "105f4167508b4d96d8df8e04cfb3d84bd7d3af8b312f852502dede706fbd61636cfba0f29d669053a109275f0761f212596ee9f18453d168da563f716b9eaa15"}], "links": [{"line": 585, "relation": "decreases", "evidence": "Abeta can also cause mitochondrial oxidative stress and dysregulation of Ca2+ homeostasis resulting in impairment of the electron transport chain (ETC), increased production of superoxide anion radical. and decreased production of ATP.", "citation": {"type": "PubMed", "reference": "15295589"}, "annotations": {"Subgraph": {"Amyloidogenic subgraph": true, "Electron transport chain": true, "Free radical formation subgraph": true}, "Confidence": {"High": true}, "Disease": {"Alzheimer's disease": true}}, "source": 31, "target": 6, "key": "878857bc202502a86664f67efc3f59d7832fb49e15d02ad7258e99697d04dee6645823d0b0626cc2f05af5fb4218ec761adeea0eede7419cb0b9647342163632"}, {"line": 7698, "relation": "increases", "evidence": "Higher APP expression and elevated Abeta levels cause greater than required Cu export, leading to increased Cu in cerebrospinal fluid (CSF) and serum, and an intracellular (IC) Cu deficiency in the brain. Cu-deficient superoxide dismutase (SOD1) contributes to the reduced antioxidant capacity of the brain, allowing further oxidative stress.", "citation": {"type": "PubMed", "reference": "15910549"}, "annotations": {"Disease": {"Alzheimer's disease": true}, "Subgraph": {"Amyloidogenic subgraph": true, "Free radical formation subgraph": true}, "MeSHAnatomy": {"Cerebrospinal Fluid": true}, "Confidence": {"Medium": true}}, "source": 31, "target": 1, "key": "01a5870f29d4f62f34d5586f6b3e41556236de66f8a4b0fe30611f5c25c211a63c5a9af3d91a1fc924245149d7ccc6134fda2538bb11a80c25840e387a04eeb7"}, {"line": 7699, "relation": "increases", "evidence": "Higher APP expression and elevated Abeta levels cause greater than required Cu export, leading to increased Cu in cerebrospinal fluid (CSF) and serum, and an intracellular (IC) Cu deficiency in the brain. Cu-deficient superoxide dismutase (SOD1) contributes to the reduced antioxidant capacity of the brain, allowing further oxidative stress.", "citation": {"type": "PubMed", "reference": "15910549"}, "annotations": {"Disease": {"Alzheimer's disease": true}, "Subgraph": {"Amyloidogenic subgraph": true, "Free radical formation subgraph": true}, "MeSHAnatomy": {"Cerebrospinal Fluid": true}, "Confidence": {"Medium": true}}, "source": 0, "target": 1, "key": "e035e593b53c7a05dee1739cec22802a98763f3fcb83b0ea2c0fa766b5283a26e72e53df56b24daa1f539309129513e6be7d2387fc49a1933fd899ffbffe3594"}, {"line": 55698, "relation": "increases", "evidence": "Here we demonstrate that Hsp60, Hsp70, and Hsp90 both alone and in combination provide differential protection against intracellular beta-amyloid stress through the maintenance of mitochondrial oxidative phosphorylation and functionality of tricarboxylic acid cycle enzymes. Notably, beta-amyloid was found to selectively inhibit complex IV activity, an effect selectively neutralized by Hsp60. The combined effect of HSPs was to reduce the free radical burden, preserve ATP generation, decrease cytochrome c release, and prevent caspase-9 activation, all important mediators of beta-amyloid-induced neuronal dysfunction and death.", "citation": {"type": "PubMed", "reference": "16887805"}, "annotations": {"Subgraph": {"Amyloidogenic subgraph": true, "Free radical formation subgraph": true}, "Confidence": {"High": true}}, "source": 0, "target": 19, "key": "fdb4ef24d50b33ec31fceb3ea2cc2edd629c25676157c76db8e0470758f9a893d30daeec5b857679979d5fa6a9cc9bb94d99f1e13c57b9d16dcbdc896caf2ded"}, {"line": 581, "relation": "decreases", "evidence": "Abeta can also cause mitochondrial oxidative stress and dysregulation of Ca2+ homeostasis resulting in impairment of the electron transport chain (ETC), increased production of superoxide anion radical. and decreased production of ATP.", "citation": {"type": "PubMed", "reference": "15295589"}, "annotations": {"Subgraph": {"Amyloidogenic subgraph": true, "Electron transport chain": true, "Free radical formation subgraph": true}, "Confidence": {"High": true}, "Disease": {"Alzheimer's disease": true}}, "source": 32, "target": 18, "key": "a8afc8789d3f19428e23934666360e140c5e1a45aa600af43b99370d6e800344effeaeb5279bb45c61f440f91aa7125230154dbf66b0c6663c3703dd7de6b3fe"}, {"line": 582, "relation": "decreases", "evidence": "Abeta can also cause mitochondrial oxidative stress and dysregulation of Ca2+ homeostasis resulting in impairment of the electron transport chain (ETC), increased production of superoxide anion radical. and decreased production of ATP.", "citation": {"type": "PubMed", "reference": "15295589"}, "annotations": {"Subgraph": {"Amyloidogenic subgraph": true, "Electron transport chain": true, "Free radical formation subgraph": true}, "Confidence": {"High": true}, "Disease": {"Alzheimer's disease": true}}, "source": 32, "target": 17, "key": "7ef649d6b174461c1f53be32327cf565a75645a22809b81214d13c4329aa78964ac753c13c57ef9ca9e017733a97327b12dcacf3375026f78b811f3e71725502"}, {"line": 583, "relation": "increases", "evidence": "Abeta can also cause mitochondrial oxidative stress and dysregulation of Ca2+ homeostasis resulting in impairment of the electron transport chain (ETC), increased production of superoxide anion radical. and decreased production of ATP.", "citation": {"type": "PubMed", "reference": "15295589"}, "annotations": {"Subgraph": {"Amyloidogenic subgraph": true, "Electron transport chain": true, "Free radical formation subgraph": true}, "Confidence": {"High": true}, "Disease": {"Alzheimer's disease": true}}, "source": 32, "target": 15, "key": "253169098f5a478f2b476c97d34ae0c0379164ef27ecc2bab0a95bd2e5eaaddfe2ead295ed70129a2bf06747617b469f0488f56986b47b187b48e1b45372822a"}, {"line": 584, "relation": "decreases", "evidence": "Abeta can also cause mitochondrial oxidative stress and dysregulation of Ca2+ homeostasis resulting in impairment of the electron transport chain (ETC), increased production of superoxide anion radical. and decreased production of ATP.", "citation": {"type": "PubMed", "reference": "15295589"}, "annotations": {"Subgraph": {"Amyloidogenic subgraph": true, "Electron transport chain": true, "Free radical formation subgraph": true}, "Confidence": {"High": true}, "Disease": {"Alzheimer's disease": true}}, "source": 32, "target": 6, "key": "d2896604ab5bb68e7aed0ebb5af7252b06215b6153e0d236f846c91404d472a4f229b1e758dd95e05a808f5b0c551742cd0cf8351a106ae8a9e050908fe946de"}, {"line": 7804, "relation": "directlyDecreases", "evidence": "Mitochondrial Abeta-binding alcohol dehydrogenase (ABAD): ABAD is a member of the short chain dehydrogenase reductase family in mitochondria that binds Abeta. Binding of Abeta to ABAD distorts the enzymebetas structure, rendering it inactive. In neurons, ABAD is predominately localized to mitochondria. Upon binding ABAD, Abeta triggers events leading to neuronal apoptosis through a mitochondrial pathway.Interestingly, mitochondrial ABAD is upregulated in neurons from AD patients. The ABAD-Abeta complex has been hypothesized to induce oxidant stress and mitochondrial dysfunction. Increased expression of ABAD exacerbates Abeta-mediated mitochondrial and neuronal stress. Abeta binding to ABAD causes free radical production and neuronal apoptotic process", "citation": {"type": "PubMed", "reference": "20847424"}, "annotations": {"Subgraph": {"Metabolism of steroid hormones subgraph": true, "Mitochondrial translocation subgraph": true, "Free radical formation subgraph": true}, "Confidence": {"High": true}, "Condition": {"Normal Healthy State": true}}, "object": {"modifier": "Activity", "effect": {"name": "cat", "namespace": "bel"}}, "source": 32, "target": 34, "key": "c40a087718d6c3bc3f6312366aa96fa98e5d90f28d779d4787e73e4762520db03b883451e57dcc684e8da647961194c870f2aa047c1dde7212e13ad6980b48c1"}, {"line": 44109, "relation": "decreases", "evidence": "Antioxidant: The three histidine residues in ABeta¸ control the redox activity of iron, indicating that ABeta¸ is likely to be an important antioxidant. ABeta¸40 at 5 Ã‚ÂµM was found to protect primary neuronal cultures from the neurotoxicity of iron [94]. Nakamura et al. [177] found that ABeta¸40 or ABeta¸42 inhibits Fe3+ or Cu+2-catalyzed ascorbate oxidation and hydroxyl radical generation. Nanomolar concentrations of ABeta¸ can block neuronal apoptosis following oxidative damage, which suggests that ABeta¸ has a protective role against oxidative stress [178] and is essential for neuronal survival [28, 94]. Monomeric ABeta¸40 was found to protect neurons cultured in a medium containing 1.5 Ã‚ÂµM Fe2+ without antioxidant molecules. However, the antioxidant protection of monomeric ABeta¸40 depends on the type of oxidant used. ABeta¸40 inhibits cultured neurondeath caused by Cu2+, Fe2+, and Fe3+ but does not protect neurons against H2O2-induced damage [94]. In cerebral cortical neuronal cultures, monomeric ABeta¸40 inhibits the reduction of Fe3+ induced by vitamin C and the generation of superoxides and prevents lipid peroxidation induced by Fe2+ [94]. Moreover, monomeric forms of ABeta¸42 also exhibited antioxidant and neuroprotective effects. However, oligomeric or aggregated ABeta¸40 and ABeta¸42 were devoid of such antioxidant activity and their neuroprotective activity was demolished. Thus, depriving neurons of the protective activity of ABeta¸42 monomers may also be an important factor in neurodegeneration [97]. These findings provide novel insights on a normal antioxidant role of ABeta¸ and indicate that monomeric ABeta¸ protects neurons by quenching metal-inducible oxygen radical generation and thereby inhibits neurotoxicity.", "citation": {"type": "PubMed", "reference": "20847424"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true, "Glutathione reductase subgraph": true}, "Confidence": {"High": true}}, "source": 32, "target": 5, "key": "63e4d42479c822d1c7adb30942098ecee07c778b6222f1bb61eecf9f0afcc5ef06b1d924ccd8c1e96255a1ef4f89112711f21cad92697191c85efda4ca768196"}, {"line": 44110, "relation": "decreases", "evidence": "Antioxidant: The three histidine residues in ABeta¸ control the redox activity of iron, indicating that ABeta¸ is likely to be an important antioxidant. ABeta¸40 at 5 Ã‚ÂµM was found to protect primary neuronal cultures from the neurotoxicity of iron [94]. Nakamura et al. [177] found that ABeta¸40 or ABeta¸42 inhibits Fe3+ or Cu+2-catalyzed ascorbate oxidation and hydroxyl radical generation. Nanomolar concentrations of ABeta¸ can block neuronal apoptosis following oxidative damage, which suggests that ABeta¸ has a protective role against oxidative stress [178] and is essential for neuronal survival [28, 94]. Monomeric ABeta¸40 was found to protect neurons cultured in a medium containing 1.5 Ã‚ÂµM Fe2+ without antioxidant molecules. However, the antioxidant protection of monomeric ABeta¸40 depends on the type of oxidant used. ABeta¸40 inhibits cultured neurondeath caused by Cu2+, Fe2+, and Fe3+ but does not protect neurons against H2O2-induced damage [94]. In cerebral cortical neuronal cultures, monomeric ABeta¸40 inhibits the reduction of Fe3+ induced by vitamin C and the generation of superoxides and prevents lipid peroxidation induced by Fe2+ [94]. Moreover, monomeric forms of ABeta¸42 also exhibited antioxidant and neuroprotective effects. However, oligomeric or aggregated ABeta¸40 and ABeta¸42 were devoid of such antioxidant activity and their neuroprotective activity was demolished. Thus, depriving neurons of the protective activity of ABeta¸42 monomers may also be an important factor in neurodegeneration [97]. These findings provide novel insights on a normal antioxidant role of ABeta¸ and indicate that monomeric ABeta¸ protects neurons by quenching metal-inducible oxygen radical generation and thereby inhibits neurotoxicity.", "citation": {"type": "PubMed", "reference": "20847424"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true, "Glutathione reductase subgraph": true}, "Confidence": {"High": true}}, "source": 32, "target": 2, "key": "4dda8a80231ad304169d80724417ecd3548e3b10b7f74b9541f84cc79d99d5f4f9a57d2e532a849a81a48bdee6386bb863a632118c5f972187808250d1c0da76"}, {"line": 44111, "relation": "decreases", "evidence": "Antioxidant: The three histidine residues in ABeta¸ control the redox activity of iron, indicating that ABeta¸ is likely to be an important antioxidant. ABeta¸40 at 5 Ã‚ÂµM was found to protect primary neuronal cultures from the neurotoxicity of iron [94]. Nakamura et al. [177] found that ABeta¸40 or ABeta¸42 inhibits Fe3+ or Cu+2-catalyzed ascorbate oxidation and hydroxyl radical generation. Nanomolar concentrations of ABeta¸ can block neuronal apoptosis following oxidative damage, which suggests that ABeta¸ has a protective role against oxidative stress [178] and is essential for neuronal survival [28, 94]. Monomeric ABeta¸40 was found to protect neurons cultured in a medium containing 1.5 Ã‚ÂµM Fe2+ without antioxidant molecules. However, the antioxidant protection of monomeric ABeta¸40 depends on the type of oxidant used. ABeta¸40 inhibits cultured neurondeath caused by Cu2+, Fe2+, and Fe3+ but does not protect neurons against H2O2-induced damage [94]. In cerebral cortical neuronal cultures, monomeric ABeta¸40 inhibits the reduction of Fe3+ induced by vitamin C and the generation of superoxides and prevents lipid peroxidation induced by Fe2+ [94]. Moreover, monomeric forms of ABeta¸42 also exhibited antioxidant and neuroprotective effects. However, oligomeric or aggregated ABeta¸40 and ABeta¸42 were devoid of such antioxidant activity and their neuroprotective activity was demolished. Thus, depriving neurons of the protective activity of ABeta¸42 monomers may also be an important factor in neurodegeneration [97]. These findings provide novel insights on a normal antioxidant role of ABeta¸ and indicate that monomeric ABeta¸ protects neurons by quenching metal-inducible oxygen radical generation and thereby inhibits neurotoxicity.", "citation": {"type": "PubMed", "reference": "20847424"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true, "Glutathione reductase subgraph": true}, "Confidence": {"High": true}}, "source": 32, "target": 20, "key": "69954496b465bee95f6bc6d591b3f7c517a683e87287705f811ca72d8649d9a1b1883d9bfb2d36b256f08ce01982ac0c61b5a0fdb137d4512c7837e5cc5600c5"}, {"line": 600, "relation": "directlyIncreases", "evidence": "Superoxide is converted to H2O2 by the activity of superoxide dismutases (SOD) and superoxide can also interact with nitric oxide (NO) to produce peroxynitrite (ONOO*)", "citation": {"type": "PubMed", "reference": "15295589"}, "annotations": {"Condition": {"Normal Healthy State": true}, "Subgraph": {"Free radical formation subgraph": true, "Hydrogen peroxide subgraph": true}, "Confidence": {"Very High": true}}, "source": 15, "target": 3, "key": "f2b1675240ad165a115f3b82252bcac2a8ee122445f097c6745613de04129e1fbc97059f4d9c59dcfd9c149720b02c63806248dd0a57030eedb39f64d944d830"}, {"line": 635, "relation": "increases", "evidence": "An alternative pathway is shown on the right side of the figure whereby superoxide or hydrogen peroxide (H2O2) oxidize lipids such as prostaglandins forming F2a-isoprostanes. Both H2O2 and F2a-isoprostanes are known to accelerate Abeta aggregation", "citation": {"type": "PubMed", "reference": "15864339"}, "annotations": {"Condition": {"Normal Healthy State": true}, "Subgraph": {"Free radical formation subgraph": true, "Hydrogen peroxide subgraph": true}, "Confidence": {"Very High": true}}, "source": 15, "target": 10, "key": "22bd8365e5d5747f74ba22bc9371ca2eaa66c2ad8689f02618eb16c1119f4613c2856513c34d98cc8aa472c85f1d287dea1c81ed1d9d76ee40180f4477b35049"}, {"line": 19989, "relation": "negativeCorrelation", "evidence": "The blood levels of catalase but not superoxide dismutase and glutathione were significantly decreased in the patients with severe AD when compared to controls (p < .01),", "citation": {"type": "PubMed", "reference": "12094909"}, "annotations": {"MeSHAnatomy": {"Blood": true}, "Subgraph": {"Free radical formation subgraph": true}, "Confidence": {"High": true}}, "source": 43, "target": 33, "key": "25e9af3c36266423b96fe7ff26ca2c96c815d954c7d4b8643fe4c699c153b7141e9c315e0d1bb02c51a4ae30ea77dea02cabd64b3a8edd198dbacb4ac6dc2c33"}, {"line": 23026, "relation": "association", "evidence": "Insufficient NRF2 activation in humans has been linked to chronic diseases such as Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis.", "citation": {"type": "PubMed", "reference": "24262633"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true}, "Confidence": {"High": true}, "MeSHDisease": {"Amyotrophic Lateral Sclerosis": true, "Alzheimer Disease": true, "Parkinson Disease": true}, "Species": {"9606": true}}, "object": {"modifier": "Activity"}, "source": 43, "target": 37, "key": "7a3446559a71870326e50f1c4e82481a188d5dacba7a4bbcc5191af0b1994f833ba4a63da333ef48652cc630cf68cc29da2e123b271bb5cc2e75bbfae018b1a7"}, {"line": 23027, "relation": "negativeCorrelation", "evidence": "Insufficient NRF2 activation in humans has been linked to chronic diseases such as Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis.", "citation": {"type": "PubMed", "reference": "24262633"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true}, "Confidence": {"High": true}, "MeSHDisease": {"Amyotrophic Lateral Sclerosis": true, "Alzheimer Disease": true, "Parkinson Disease": true}, "Species": {"9606": true}}, "object": {"modifier": "Activity"}, "source": 43, "target": 37, "key": "ef041f524f5fa47b10439d364c6ee9827313fd298eb6a116b099cf1445e56d87495a056f4d4d5f84d4dc12e4e2c39d03528683b4faf0bbdf0fd1dcbd60d8d273"}, {"line": 23132, "relation": "association", "evidence": "Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract.", "citation": {"type": "PubMed", "reference": "20064547"}, "annotations": {"MeSHDisease": {"Cataract": true, "Alzheimer Disease": true}, "Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true, "Reactive oxygen species subgraph": true}, "Confidence": {"High": true}}, "source": 43, "target": 37, "key": "56e69bb914ffabd4c3e03307b0f4bae20100d0b229c15baa0bd8a43f8a3fe41ca34a4563200e19ebe6a1a54bb1f39595c33138a34981c019723d63bf37a23f78"}, {"line": 19989, "relation": "negativeCorrelation", "evidence": "The blood levels of catalase but not superoxide dismutase and glutathione were significantly decreased in the patients with severe AD when compared to controls (p < .01),", "citation": {"type": "PubMed", "reference": "12094909"}, "annotations": {"MeSHAnatomy": {"Blood": true}, "Subgraph": {"Free radical formation subgraph": true}, "Confidence": {"High": true}}, "source": 33, "target": 43, "key": "1ea32a3096838f54200f237f591e3e88e572820f236e12e41e7f8ad3f6456544e8c0d94e695026971fe6915d9db48eec77b1914257f17a800e4db9b2943a7988"}, {"line": 23024, "relation": "association", "evidence": "Insufficient NRF2 activation in humans has been linked to chronic diseases such as Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis.", "citation": {"type": "PubMed", "reference": "24262633"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true}, "Confidence": {"High": true}, "MeSHDisease": {"Amyotrophic Lateral Sclerosis": true, "Alzheimer Disease": true, "Parkinson Disease": true}, "Species": {"9606": true}}, "subject": {"modifier": "Activity"}, "source": 37, "target": 44, "key": "af06b2eaa8d1e24df0b09177aacdad916857bc2c273d437e4a9ce054e54e3ec79671c81ecfa137524a4929d347d0807db66c20c7e5dde7ab8d4a583f8c201872"}, {"line": 23025, "relation": "negativeCorrelation", "evidence": "Insufficient NRF2 activation in humans has been linked to chronic diseases such as Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis.", "citation": {"type": "PubMed", "reference": "24262633"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true}, "Confidence": {"High": true}, "MeSHDisease": {"Amyotrophic Lateral Sclerosis": true, "Alzheimer Disease": true, "Parkinson Disease": true}, "Species": {"9606": true}}, "subject": {"modifier": "Activity"}, "source": 37, "target": 44, "key": "4be292f165b8c571e455e16373938e1a76258739c406b9dd460de0d56abfc40d359ed33763aa0152ebdb72af8a36299b16598bc875e31c5f1a7e4037eebe71a2"}, {"line": 23026, "relation": "association", "evidence": "Insufficient NRF2 activation in humans has been linked to chronic diseases such as Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis.", "citation": {"type": "PubMed", "reference": "24262633"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true}, "Confidence": {"High": true}, "MeSHDisease": {"Amyotrophic Lateral Sclerosis": true, "Alzheimer Disease": true, "Parkinson Disease": true}, "Species": {"9606": true}}, "subject": {"modifier": "Activity"}, "source": 37, "target": 43, "key": "fe079ebae01e0f5ca7dc17c09d82602a46d8240274d1c69fc5f287cf2fdcc7142f3eb3c51ded5fdbd3c74b33860c0a268fe792449bc085686cc9dcb0593d70f1"}, {"line": 23027, "relation": "negativeCorrelation", "evidence": "Insufficient NRF2 activation in humans has been linked to chronic diseases such as Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis.", "citation": {"type": "PubMed", "reference": "24262633"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true}, "Confidence": {"High": true}, "MeSHDisease": {"Amyotrophic Lateral Sclerosis": true, "Alzheimer Disease": true, "Parkinson Disease": true}, "Species": {"9606": true}}, "subject": {"modifier": "Activity"}, "source": 37, "target": 43, "key": "0673a1348d44c31b31ee85a4f4202de5b0d8427805d0dfbb7497563b43d0e39a51137d07a52609e986003c5f22b66be2792842ed46f0dd40c077eb5ebe66e621"}, {"line": 23132, "relation": "association", "evidence": "Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract.", "citation": {"type": "PubMed", "reference": "20064547"}, "annotations": {"MeSHDisease": {"Cataract": true, "Alzheimer Disease": true}, "Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true, "Reactive oxygen species subgraph": true}, "Confidence": {"High": true}}, "source": 37, "target": 43, "key": "d3ec983c4d6b9097e47a58b1307cff76744ba578a5f7712f2a1776493cbf157871624ca92163ae6e8b334627fb7ffb3fb682b209d0230063b878dbd268449497"}, {"line": 23028, "relation": "association", "evidence": "Insufficient NRF2 activation in humans has been linked to chronic diseases such as Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis.", "citation": {"type": "PubMed", "reference": "24262633"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true}, "Confidence": {"High": true}, "MeSHDisease": {"Amyotrophic Lateral Sclerosis": true, "Alzheimer Disease": true, "Parkinson Disease": true}, "Species": {"9606": true}}, "subject": {"modifier": "Activity"}, "source": 37, "target": 46, "key": "4e856bec7c20b34e0dce8b58def02dbcdfc455b871ca1eb12ca025bfe0a708cf0465081def9b7141d25809d902387668f5ecfce37395c20cbbff1350dd638733"}, {"line": 23029, "relation": "negativeCorrelation", "evidence": "Insufficient NRF2 activation in humans has been linked to chronic diseases such as Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis.", "citation": {"type": "PubMed", "reference": "24262633"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true}, "Confidence": {"High": true}, "MeSHDisease": {"Amyotrophic Lateral Sclerosis": true, "Alzheimer Disease": true, "Parkinson Disease": true}, "Species": {"9606": true}}, "subject": {"modifier": "Activity"}, "source": 37, "target": 46, "key": "c700cb94c08ac39df4c73e9944b055fa169172234525e32a76f4ee8daa537bcdc016fc9cda5f46819b739b0bf054aba390a18d8fd69bfbfbba2773a89068d9df"}, {"line": 23060, "relation": "association", "evidence": "We bring forward the hypothesis that inflammation via prolonged activation of key kinases (p38 and GSK-3beta) and activation of histone deacetylases gives rise to dysregulation of the NRF2 system in the brain, which contributes to oxidative stress and injury.", "citation": {"type": "PubMed", "reference": "24262633"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true}, "Confidence": {"High": true}, "MeSHDisease": {"Inflammation": true, "Wounds and Injuries": true}}, "subject": {"modifier": "Activity"}, "source": 37, "target": 48, "key": "af0c10f46e319d1209f86e7748085496d7abb936decf3403506aecaa117ede04f7118d6fd1180f81c61d936fd8787580267a76824d73325621fef6ee78377bd1"}, {"line": 23061, "relation": "association", "evidence": "We bring forward the hypothesis that inflammation via prolonged activation of key kinases (p38 and GSK-3beta) and activation of histone deacetylases gives rise to dysregulation of the NRF2 system in the brain, which contributes to oxidative stress and injury.", "citation": {"type": "PubMed", "reference": "24262633"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true}, "Confidence": {"High": true}, "MeSHDisease": {"Inflammation": true, "Wounds and Injuries": true}}, "subject": {"modifier": "Activity"}, "object": {"modifier": "Activity"}, "source": 37, "target": 36, "key": "766d3b03963e4dc5457352564ca8b23e7bb98d6ded1aa9fee5e27a85d896ea74dd98c839f407ab0fd16c2c2e40c3d3076be79d8d7b0c6a6dc8c71d83299a0675"}, {"line": 23073, "relation": "association", "evidence": "We bring forward the hypothesis that inflammation via prolonged activation of key kinases (p38 and GSK-3beta) and activation of histone deacetylases gives rise to dysregulation of the NRF2 system in the brain, which contributes to oxidative stress and injury.", "citation": {"type": "PubMed", "reference": "24262633"}, "annotations": {"MeSHDisease": {"Inflammation": true, "Wounds and Injuries": true}, "Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true}, "Confidence": {"High": true}}, "subject": {"modifier": "Activity"}, "source": 37, "target": 21, "key": "ce8a6f96f3a26864294b0cfa028dfc3b334194aa128ce5a6a6d5a8bfa4a339989ce5b1b46b7576f4bfbdd45d79255266bf217f14de06ed4487b1a61102cc509f"}, {"line": 23074, "relation": "association", "evidence": "We bring forward the hypothesis that inflammation via prolonged activation of key kinases (p38 and GSK-3beta) and activation of histone deacetylases gives rise to dysregulation of the NRF2 system in the brain, which contributes to oxidative stress and injury.", "citation": {"type": "PubMed", "reference": "24262633"}, "annotations": {"MeSHDisease": {"Inflammation": true, "Wounds and Injuries": true}, "Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true}, "Confidence": {"High": true}}, "subject": {"modifier": "Activity"}, "source": 37, "target": 25, "key": "b69502099976e238a79d35678635ed949c5104c244b14ad112bd928ec865ec47408c473fd095b4313347ba23b3054db5298392c481609d5acb0b41c16b97439e"}, {"line": 23145, "relation": "association", "evidence": "We hypothesize that common variants of NFE2L2 and KEAP1, the genes encoding the main regulators of the Nrf2 system, an important defence system against oxidative stress, may influence risk of AD and/or age-related cataract.", "citation": {"type": "PubMed", "reference": "20064547"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true, "Reactive oxygen species subgraph": true}, "Confidence": {"High": true}}, "source": 37, "target": 25, "key": "d8bc8aac126b486c1c82c0031da4fd2c96156183123591656bc20dbd841df1fd7d68570b1270be01508fab578b8bd5d061038c1aa5b8671e8473cd18e656c714"}, {"line": 23075, "relation": "association", "evidence": "We bring forward the hypothesis that inflammation via prolonged activation of key kinases (p38 and GSK-3beta) and activation of histone deacetylases gives rise to dysregulation of the NRF2 system in the brain, which contributes to oxidative stress and injury.", "citation": {"type": "PubMed", "reference": "24262633"}, "annotations": {"MeSHDisease": {"Inflammation": true, "Wounds and Injuries": true}, "Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true}, "Confidence": {"High": true}}, "subject": {"modifier": "Activity"}, "source": 37, "target": 47, "key": "d7eb7e161d8f742ddb5c3c00d2b66da2c0bf89ad79b169b013d09e0340dac00b65a70aa36afca5a14a7cfe9a77084b261d5bbbed84aa8e148f96e01b0b628159"}, {"line": 47775, "relation": "increases", "evidence": "However, in response to oxidative stress, NRF2 translocates to the nucleus and binds to specific DNA sites termed \\\"anti-oxidant response elements\\\" or \\\"electrophile response elements\\\" to initiate transcription of cytoprotective genes.", "citation": {"type": "PubMed", "reference": "24262633"}, "annotations": {"Subgraph": {"Response to oxidative stress": true, "Free radical formation subgraph": true}, "Confidence": {"Medium": true}}, "source": 37, "target": 23, "key": "8b6ae1a08ebace4864f08b55f33640a49c3af4831fa59b59fa274c13327b039a919bb18d36d8905f13b769db15d0c846da44160fd1bebd058fda503ded1b9904"}, {"line": 639, "relation": "directlyIncreases", "evidence": "An alternative pathway is shown on the right side of the figure whereby superoxide or hydrogen peroxide (H2O2) oxidize lipids such as prostaglandins forming F2a-isoprostanes. Both H2O2 and F2a-isoprostanes are known to accelerate Abeta aggregation", "citation": {"type": "PubMed", "reference": "15864339"}, "annotations": {"Condition": {"Normal Healthy State": true}, "Subgraph": {"Free radical formation subgraph": true, "Hydrogen peroxide subgraph": true}, "Confidence": {"Very High": true}}, "source": 3, "target": 10, "key": "5e2290de88255bf569ff1cd946537528acf5f64e95272ce1a41950e87628d31bc5c0d4e90e69644e9a9df4ad78a0715727cea2935f5d61bc519e332e269926eb"}, {"line": 616, "relation": "directlyIncreases", "evidence": "Interaction of H2O2 with Fe2+ or Cu+ generates hydroxyl radical (OH*) a highly reactive oxyradical and potent inducer of MAOS", "citation": {"type": "PubMed", "reference": "15295589"}, "annotations": {"Condition": {"Normal Healthy State": true}, "Subgraph": {"Free radical formation subgraph": true, "Hydrogen peroxide subgraph": true}, "Confidence": {"Very High": true}}, "source": 27, "target": 4, "key": "ffb79f7c14d6258109f73b3f6b580f81ab2598cc953d8b3bed88a25a5ddecca22b9a6fb3983bf23489cdf47a40200b8b1c5f36afbb978edeeb2f4c8631382dbc"}, {"line": 617, "relation": "directlyIncreases", "evidence": "Interaction of H2O2 with Fe2+ or Cu+ generates hydroxyl radical (OH*) a highly reactive oxyradical and potent inducer of MAOS", "citation": {"type": "PubMed", "reference": "15295589"}, "annotations": {"Condition": {"Normal Healthy State": true}, "Subgraph": {"Free radical formation subgraph": true, "Hydrogen peroxide subgraph": true}, "Confidence": {"Very High": true}}, "source": 26, "target": 4, "key": "32efe47552e8d81f8ea69b81d6155b68ed66116f2e39049da2ce113045aac0f0198c7398d7092e99acd2332c8a3ca78e1d50b11056e17bf167d895894f1aa88d"}, {"line": 24680, "relation": "increases", "evidence": "Melatonin also enhances the antioxidant potential of the cell by stimulating the synthesis of antioxidant enzymes like superoxide dismutase, glutathione peroxidase and glutathione reductase, and by augmenting glutathione levels.", "citation": {"type": "PubMed", "reference": "16179266"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true}, "Confidence": {"Very High": true}}, "source": 9, "target": 30, "key": "c9f059f71f0530658dfae449bebbd7844e5123e934dbb56f37bc93f5aab0ebcd287cfc19d4be18d7f76148d54426283b3e1113e7366032f4696287f058271663"}, {"line": 24681, "relation": "increases", "evidence": "Melatonin also enhances the antioxidant potential of the cell by stimulating the synthesis of antioxidant enzymes like superoxide dismutase, glutathione peroxidase and glutathione reductase, and by augmenting glutathione levels.", "citation": {"type": "PubMed", "reference": "16179266"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true}, "Confidence": {"Very High": true}}, "source": 9, "target": 29, "key": "8cf7cbb7169f5e3a356abebd24f53a26a0a95dabf1444428cbe2f72b286b208bbe43a055103bd344a1453c62a3a318743482f5f688ecd3c333a1b9ba0f44fca1"}, {"line": 24682, "relation": "equivalentTo", "evidence": "Melatonin also enhances the antioxidant potential of the cell by stimulating the synthesis of antioxidant enzymes like superoxide dismutase, glutathione peroxidase and glutathione reductase, and by augmenting glutathione levels.", "citation": {"type": "PubMed", "reference": "16179266"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true}, "Confidence": {"Very High": true}}, "source": 30, "target": 29, "key": "211af7f8bc69b5c345a7fd3b0186f4abd6883e84fbbf90d3cd3aba251ead8d8e68ffd20bdaa3f3c8ef55039dbf2dbafd66d4e2243ddefc748cb1c7313ecd5cb3"}, {"line": 24682, "relation": "equivalentTo", "evidence": "Melatonin also enhances the antioxidant potential of the cell by stimulating the synthesis of antioxidant enzymes like superoxide dismutase, glutathione peroxidase and glutathione reductase, and by augmenting glutathione levels.", "citation": {"type": "PubMed", "reference": "16179266"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true}, "Confidence": {"Very High": true}}, "source": 29, "target": 30, "key": "c301752089d17d25a44bba6c37853b8766541196b0da2d92d3e05c39dbe27738c539b2c5ce19f91ab0ef426d6c1523b7cc105c94a2f2a3cfef48203b33352e6f"}, {"line": 23028, "relation": "association", "evidence": "Insufficient NRF2 activation in humans has been linked to chronic diseases such as Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis.", "citation": {"type": "PubMed", "reference": "24262633"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true}, "Confidence": {"High": true}, "MeSHDisease": {"Amyotrophic Lateral Sclerosis": true, "Alzheimer Disease": true, "Parkinson Disease": true}, "Species": {"9606": true}}, "object": {"modifier": "Activity"}, "source": 46, "target": 37, "key": "6bbd4392a2660637c926cf095c40fb3f4debe60898956fc31a5892b8a5c294f276eb58e35d2e05413efa277fb3baacdbab85566962f93623696017c330ae9bf9"}, {"line": 23029, "relation": "negativeCorrelation", "evidence": "Insufficient NRF2 activation in humans has been linked to chronic diseases such as Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis.", "citation": {"type": "PubMed", "reference": "24262633"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true}, "Confidence": {"High": true}, "MeSHDisease": {"Amyotrophic Lateral Sclerosis": true, "Alzheimer Disease": true, "Parkinson Disease": true}, "Species": {"9606": true}}, "object": {"modifier": "Activity"}, "source": 46, "target": 37, "key": "3147ee72fa4095c50fb79b737c64b93f37aa84f6809ba07ce46cd43ce06e80ce66ef780aac1b441b3de5ae422f81b91220c8e937abe5a8d0a258712b8f160171"}, {"line": 23061, "relation": "association", "evidence": "We bring forward the hypothesis that inflammation via prolonged activation of key kinases (p38 and GSK-3beta) and activation of histone deacetylases gives rise to dysregulation of the NRF2 system in the brain, which contributes to oxidative stress and injury.", "citation": {"type": "PubMed", "reference": "24262633"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true}, "Confidence": {"High": true}, "MeSHDisease": {"Inflammation": true, "Wounds and Injuries": true}}, "subject": {"modifier": "Activity"}, "object": {"modifier": "Activity"}, "source": 36, "target": 37, "key": "d12f90ef7eae0e73d9d4e0364a5882ecbb7e57dc50900935b2e6cae71e5af5eb902962589ce094c4c3d460641c5d1c31e1035fdcec28e69814a1e0d58ce90b17"}, {"line": 24731, "relation": "increases", "evidence": "Melatonin's efficacy in combating free radical damage in the brain suggests that it may be a valuable therapeutic agent in the treatment of cerebral edema after traumatic brain injury.", "citation": {"type": "PubMed", "reference": "16179266"}, "annotations": {"MeSHDisease": {"Brain Injuries": true, "Brain Edema": true}, "MeSHAnatomy": {"Brain": true, "Cerebrum": true}, "Subgraph": {"Free radical formation subgraph": true}, "Confidence": {"Medium": true}}, "subject": {"modifier": "Activity"}, "source": 12, "target": 45, "key": "3fabdbc93468163b7beea505bbf34f16ce417f8c3be590e983849c663e7471ce2b127d7044155961ca0ffaf137509d3a42391607ff37670908a90d7006e580f3"}, {"line": 7805, "relation": "increases", "evidence": "Mitochondrial Abeta-binding alcohol dehydrogenase (ABAD): ABAD is a member of the short chain dehydrogenase reductase family in mitochondria that binds Abeta. Binding of Abeta to ABAD distorts the enzymebetas structure, rendering it inactive. In neurons, ABAD is predominately localized to mitochondria. Upon binding ABAD, Abeta triggers events leading to neuronal apoptosis through a mitochondrial pathway.Interestingly, mitochondrial ABAD is upregulated in neurons from AD patients. The ABAD-Abeta complex has been hypothesized to induce oxidant stress and mitochondrial dysfunction. Increased expression of ABAD exacerbates Abeta-mediated mitochondrial and neuronal stress. Abeta binding to ABAD causes free radical production and neuronal apoptotic process", "citation": {"type": "PubMed", "reference": "20847424"}, "annotations": {"Subgraph": {"Metabolism of steroid hormones subgraph": true, "Mitochondrial translocation subgraph": true, "Free radical formation subgraph": true}, "Confidence": {"High": true}, "Condition": {"Normal Healthy State": true}}, "source": 28, "target": 16, "key": "184e86ddcb1c033a94e99ff757d52b7a56cfbf76c13971c6de45cfe4ab633d69bcae014a65f5acfa7eb45e46f3f8776221f201aacf05523c396326384b123d20"}, {"line": 23074, "relation": "association", "evidence": "We bring forward the hypothesis that inflammation via prolonged activation of key kinases (p38 and GSK-3beta) and activation of histone deacetylases gives rise to dysregulation of the NRF2 system in the brain, which contributes to oxidative stress and injury.", "citation": {"type": "PubMed", "reference": "24262633"}, "annotations": {"MeSHDisease": {"Inflammation": true, "Wounds and Injuries": true}, "Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true}, "Confidence": {"High": true}}, "object": {"modifier": "Activity"}, "source": 25, "target": 37, "key": "7f3c9ec3b71fd23ad92e3337838120a839271cbc772ff2c47624cc957ca81dfb08d009ad12a705be27ece1be432c6494375d8cbf55915bfabdcc1a46ef2b5012"}, {"line": 23145, "relation": "association", "evidence": "We hypothesize that common variants of NFE2L2 and KEAP1, the genes encoding the main regulators of the Nrf2 system, an important defence system against oxidative stress, may influence risk of AD and/or age-related cataract.", "citation": {"type": "PubMed", "reference": "20064547"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true, "Reactive oxygen species subgraph": true}, "Confidence": {"High": true}}, "source": 25, "target": 37, "key": "628b2c21aa67637186ea4360c7ae0e5dba4447794ce78a901e65b6ad818d1d93a6c0f6083fa556365ca1f1145ac5b939378186b45421d52fac8fd8ad01e4ab3b"}, {"line": 23149, "relation": "association", "evidence": "We hypothesize that common variants of NFE2L2 and KEAP1, the genes encoding the main regulators of the Nrf2 system, an important defence system against oxidative stress, may influence risk of AD and/or age-related cataract.", "citation": {"type": "PubMed", "reference": "20064547"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true, "Reactive oxygen species subgraph": true}, "Confidence": {"High": true}}, "source": 25, "target": 35, "key": "797a8ff5cec4ed0df21d70a745ec1ff24a872461d5a8d316ce62a2561d0c99a35fda71a63922f70ac6254b0ebc4f93f308e5ee3d32f0b80eb1c2b8c912638934"}, {"line": 23149, "relation": "association", "evidence": "We hypothesize that common variants of NFE2L2 and KEAP1, the genes encoding the main regulators of the Nrf2 system, an important defence system against oxidative stress, may influence risk of AD and/or age-related cataract.", "citation": {"type": "PubMed", "reference": "20064547"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true, "Reactive oxygen species subgraph": true}, "Confidence": {"High": true}}, "source": 35, "target": 25, "key": "a00ced16e58b7c425fea1572171cf89ddc33d818d3c4510be6d3af9c8c6beb1ca3fb07637c2f79d49089597f4e3f4ef5df0d1d6cd37f376700d80ccc5ee8b84c"}, {"line": 23060, "relation": "association", "evidence": "We bring forward the hypothesis that inflammation via prolonged activation of key kinases (p38 and GSK-3beta) and activation of histone deacetylases gives rise to dysregulation of the NRF2 system in the brain, which contributes to oxidative stress and injury.", "citation": {"type": "PubMed", "reference": "24262633"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true}, "Confidence": {"High": true}, "MeSHDisease": {"Inflammation": true, "Wounds and Injuries": true}}, "object": {"modifier": "Activity"}, "source": 48, "target": 37, "key": "b5059160e7cb317432247ac106a0d38400ff86adfba0a81090ce4b5f4547afc82c5ce876d184cace37c8d5179b25da2ee07231ea7739b667ae6233dba20f9402"}, {"line": 29383, "relation": "increases", "evidence": "Rivastigmine (1 and 2 mg/kg, p.o.) administration attenuated lipid peroxidation, nitrite levels and restored the decrease levels of SOD and catalase activities in striatum, cortex and hippocampus areas of 3-NP treated rats as compared to vehicle treated rats", "citation": {"type": "PubMed", "reference": "19445928"}, "annotations": {"Species": {"10116": true}, "Subgraph": {"Free radical formation subgraph": true}, "Confidence": {"High": true}}, "source": 13, "target": 41, "key": "191d239326a6b97a6dbfdb6c06ce3bcb73c3ea2dd454993f4921b5a61d01dbb77d9605b031b975cb5c3aa74959d9075e8ed2b2c3615debe07fad4bcb68afc0a2"}, {"line": 29384, "relation": "increases", "evidence": "Rivastigmine (1 and 2 mg/kg, p.o.) administration attenuated lipid peroxidation, nitrite levels and restored the decrease levels of SOD and catalase activities in striatum, cortex and hippocampus areas of 3-NP treated rats as compared to vehicle treated rats", "citation": {"type": "PubMed", "reference": "19445928"}, "annotations": {"Species": {"10116": true}, "Subgraph": {"Free radical formation subgraph": true}, "Confidence": {"High": true}}, "source": 13, "target": 42, "key": "f6fa003c09090e8fcba0800909233fdafdbcab9386f05d58ec237a1f77ae271e45f50c6c542ae973cb55e55d9a419c1eca8b6b36445d25bb6690096f592b1b86"}, {"line": 17226, "relation": "increases", "evidence": "We found a significant reduction of calyculin A-induced tau hyperphosphorylation at Ser198/199/202, Ser396, Ser404, Thr205, and Thr231 24 h after treatment with 20 Î¼g/ml berberine. Berberine also restored protein phosphates 2A activity and reversed glycogen synthase kinase-3beta (GSK-3beta) activation, as determined by phosphatase activity assay and GSK-3beta phosphorylation at Tyr216 and Ser9, respectively. Furthermore, berberine reversed both the increase of malondialdehyde and the decrease of superoxide dismutase activity induced by calyculin A, indicating its role in anti-oxidative stress.", "citation": {"type": "PubMed", "reference": "21297267"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true}, "Confidence": {"Medium": true}}, "object": {"modifier": "Activity"}, "source": 8, "target": 38, "key": "b933382c5c08ef9bbb9b42c5356e70b4fb3af2d70fb85993a1972c38a4aea1e6fc4931a1174df3aabab5ad233980162c0177fce37d2c2c227c293e255276d7d2"}, {"line": 23075, "relation": "association", "evidence": "We bring forward the hypothesis that inflammation via prolonged activation of key kinases (p38 and GSK-3beta) and activation of histone deacetylases gives rise to dysregulation of the NRF2 system in the brain, which contributes to oxidative stress and injury.", "citation": {"type": "PubMed", "reference": "24262633"}, "annotations": {"MeSHDisease": {"Inflammation": true, "Wounds and Injuries": true}, "Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true}, "Confidence": {"High": true}}, "object": {"modifier": "Activity"}, "source": 47, "target": 37, "key": "e8f25520d3e314d7a56b6e2f11e5f26f3390dbbb6e6f7befebb902f527bc350787be579d9550d3debe61a2c0af0de82699db5636e703c59b3bf4f19e25f89e2b"}, {"line": 19513, "relation": "increases", "evidence": "In the mechanistic studies, IRN significantly increased the level of glutathione (GSH) and the activities of superoxide dismutase (SOD) and catalase (CAT), while decreased the level of malondialdehyde (MDA) in the brain tissues of the D-gal-treated mice.", "citation": {"type": "PubMed", "reference": "24984171"}, "annotations": {"MeSHAnatomy": {"Brain": true}, "Subgraph": {"Free radical formation subgraph": true}, "Confidence": {"Medium": true}}, "source": 7, "target": 22, "key": "ec8736bccbed792f11290a14be528779b232788a2edef629d0aaefa7c823dc648c8e0e494ff6c627c611b2f0eb71ad89201a99bd4362aa871080400c11f4f45d"}, {"line": 23024, "relation": "association", "evidence": "Insufficient NRF2 activation in humans has been linked to chronic diseases such as Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis.", "citation": {"type": "PubMed", "reference": "24262633"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true}, "Confidence": {"High": true}, "MeSHDisease": {"Amyotrophic Lateral Sclerosis": true, "Alzheimer Disease": true, "Parkinson Disease": true}, "Species": {"9606": true}}, "object": {"modifier": "Activity"}, "source": 44, "target": 37, "key": "f936a2203ed980c75bcb1bc53a20e158d1f98738e5ae3a19fdf5b93b873d9bfd097aa819eec768b6a1fb65aa909dee8013cca721b23dd3a37a985775bea9ebad"}, {"line": 23025, "relation": "negativeCorrelation", "evidence": "Insufficient NRF2 activation in humans has been linked to chronic diseases such as Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis.", "citation": {"type": "PubMed", "reference": "24262633"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true}, "Confidence": {"High": true}, "MeSHDisease": {"Amyotrophic Lateral Sclerosis": true, "Alzheimer Disease": true, "Parkinson Disease": true}, "Species": {"9606": true}}, "object": {"modifier": "Activity"}, "source": 44, "target": 37, "key": "fb673c11244dbc0a415a3f8a4175414135c7a70d2417a8d3ccfe5a2fbc64d36375a12dff1449cd5de650aa70a124191613a91a7e1a3c61fe7bbae6b0f28258d5"}, {"line": 23073, "relation": "association", "evidence": "We bring forward the hypothesis that inflammation via prolonged activation of key kinases (p38 and GSK-3beta) and activation of histone deacetylases gives rise to dysregulation of the NRF2 system in the brain, which contributes to oxidative stress and injury.", "citation": {"type": "PubMed", "reference": "24262633"}, "annotations": {"MeSHDisease": {"Inflammation": true, "Wounds and Injuries": true}, "Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true}, "Confidence": {"High": true}}, "object": {"modifier": "Activity"}, "source": 21, "target": 37, "key": "959e6515ad8eec8a2f98a0c38e56791312b4a8040786cdde830c22754a3018fe866ae8104f902e7af75179e032655f0443420bd0a99b799082711f41c57fc0b8"}, {"line": 23098, "relation": "increases", "evidence": "Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease.", "citation": {"type": "PubMed", "reference": "19805328"}, "annotations": {"Species": {"10090": true}, "Disease": {"Alzheimer's disease": true}, "MeSHAnatomy": {"Hippocampus": true}, "Subgraph": {"Free radical formation subgraph": true, "Inflammatory response subgraph": true}, "Confidence": {"Medium": true}}, "source": 39, "target": 24, "key": "533fa67308653d5fbbcb989d36b0676d7c74d3ba7c824d8a0750259a2340b1e62014028a2ddef6ce2f63876869192841a0782b746e38b71943af9009add06d6d"}, {"line": 24673, "relation": "increases", "evidence": "Melatonin also enhances the antioxidant potential of the cell by stimulating the synthesis of antioxidant enzymes like superoxide dismutase, glutathione peroxidase and glutathione reductase, and by augmenting glutathione levels.", "citation": {"type": "PubMed", "reference": "16179266"}, "annotations": {"Subgraph": {"Free radical formation subgraph": true, "Glutathione reductase subgraph": true}, "Confidence": {"Very High": true}}, "source": 11, "target": 9, "key": "942fd84b85bde59e5b2796be377e27a91297ead37472a72b120a50a84acb4a986d20f0f8f7ea78d43121f2e74a1810418bb51dec744d1987e6c96141e20e74d0"}, {"line": 24730, "relation": "decreases", "evidence": "Melatonin's efficacy in combating free radical damage in the brain suggests that it may be a valuable therapeutic agent in the treatment of cerebral edema after traumatic brain injury.", "citation": {"type": "PubMed", "reference": "16179266"}, "annotations": {"MeSHDisease": {"Brain Injuries": true, "Brain Edema": true}, "MeSHAnatomy": {"Brain": true, "Cerebrum": true}, "Subgraph": {"Free radical formation subgraph": true}, "Confidence": {"Medium": true}}, "object": {"modifier": "Activity"}, "source": 11, "target": 12, "key": "02481f0608481c358dcc6fcb3da234ab56d529c705200690a1921f442f6438debcdffeaec88c72be7a6a99db71e5bfc4220ffba98edc3a69fcd7ff942f51e90a"}, {"line": 50998, "relation": "increases", "evidence": "Results demonstrated that orally administered rutin significantly attenuated memory deficits in AD transgenic mice, decreased oligomeric Abeta level, increased super oxide dismutase (SOD) activity and glutathione (GSH)/glutathione disulfide (GSSG) ratio, reduced GSSG and malondialdehyde (MDA) levels, downregulated microgliosis and astrocytosis, and decreased interleukin (IL)-1beta and IL-6 levels in the brain.", "citation": {"type": "PubMed", "reference": "24512768"}, "annotations": {"Disease": {"Alzheimer's disease": true}, "Subgraph": {"Free radical formation subgraph": true}, "MeSHAnatomy": {"Brain": true}, "Species": {"10090": true}, "Confidence": {"High": true}}, "object": {"modifier": "Activity"}, "source": 14, "target": 40, "key": "e69657050a170f9a040e6314c943f7c9fff944ad0684d1bf70452de1c161236e1b8853db7e16469ed275ea7f052d0301baa54330ec59c5207c00705746be65ee"}]}